CAV1 and systemic sclerosis: This could explain why African American patients have a higher susceptibility to developing SSc‐ILD compared to Caucasians, highlighting Cav‐1's role in promoting pulmonary fibrosis by regulating signaling pathways, cell migration, and fibroblast differentiation [86, 106].